Cambridge NeuroWorks drives UK neurotech forward with launch of nationwide Blue Sky Proof-of-Concept Fund
Cambridge NeuroWorks announces a new UK-wide initiative designed to power high-risk, high-impact experimentation in early-stage neurotechnology.
Beta Launch of LYEONS Heart
The Beta Launch of 23 LYEONS Heart devices is now live!
VALANX Biotech establishes Board of Directors
Renowned industry leaders, Michael Boehler, Alexander Schwartz, Urs Spitz and Ingo Nagler, appointed to guide strategic and commercial development
Enterprise Therapeutics publishes results of Phase 1 study of ETD001, a novel inhaled ENaC blocker for treatment of Cystic Fibrosis, in The Journal of Cystic Fibrosis
ETD001 is well tolerated in healthy individuals at higher doses than predicted to be therapeutic for long-lasting enhancement of mucociliary clearanceResults showed excellent consistency between preclinical and clinical behaviour of ETD001Phase 2 trial
UK health: Focus on prevention can deliver £8 for each £1 invested
UK has the potential to unlock £8 in socio-economic returns for every £1 spent on preventive healthcare, according to new Deloitte analysis; Increasing prevention spend from current 6% to 10% could lead to £42 billion of savings to the UK healthcare system in 10 years; A 7% reduction in preventable deaths could save over 5,400 lives annually, with a societal value of £6 billion.
Life sciences talent development when the half-life of knowledge shrinks
By Excellence First Enterprise Consultancy (EFEC).
Beacon’s Patient Group Mentoring Programme 26 – 27
Become a mentor on Beacon’s Patient Group Mentoring Programme and make a real difference to the rare disease community! Applications are open until the 19th of December.
Lab Thread announces Beta release of Unified Lab Software Platform
Designed to streamline collaboration across biological research, combining real-time data management, analysis, DNA sequence design, chat and review functions within one intuitive, easy to use systemInterested parties invited to register for beta access via the Lab Thre
Guardtech Group sign off record-breaking 2025 in style with a series of ground-breaking projects that are set to protect, preserve and improve human life
The East Anglian cleanroom construction specialists racked up more projects this year than ever before – including some very special life-saving ventures
Royal Papworth Hospital: A lifeline of connectivity during a crisis
Royal Papworth Hospital, located on the Cambridge Biomedical Campus, stands as a world-renowned centre for heart and lung care, serving 4,000 staff, patients, and visitors each day.
SCORES Athlete project relaunches with a fresh design on Mantal
The SCORES Athlete project—focused on understanding long-term health outcomes related to sports participation—has been refreshed and relaunched using Mantal’s modern digital infrastructure to enhance participant engagement and expand study reach.
Cambridge-based business leader Sarah Mardle named on the 2025 UK Kindness and Leadership list
Sarah Mardle, CEO and Founder of Alma Business Consulting, has been recognised on the 2025 UK Kindness and Leadership list, sponsored by the Financial Times, the
Rapsodi & PD-Frontline studies successfully migrate to Mantal
The Rapsodi and PD-Frontline Parkinson’s studies have officially migrated to Mantal, enabling researchers to consolidate study operations, improve participant engagement, and future-proof their digital research infrastructure.
PREDICT-PD, the largest UK cross-sectional Parkinson’s study, adopts Mantal
PREDICT-PD, one of the UK’s most important Parkinson’s research initiatives, is now using the Mantal platform to expand participant reach, streamline digital assessments, and accelerate its mission to identify early markers of Parkinson’s disease.
TRIMTECH Therapeutics appoints Alison Lawton as Chair of the Board
Experienced biotech Chair and executive will guide corporate growth and development
Atelerix and Labskin partner to enable long-distance transport of advanced in vitro skin models
Agreement to broaden access, streamline logistics, and reduce variability associated with temperature-sensitive shipping of 3D tissue models, without cryopreservationJoint webinar to present trial performance data and best-practice workflows for global research communit
Why startups are choosing Peterborough
For years, Cambridge has dominated conversations about innovation in the East of England. But whilst Cambridge continues to thrive, something interesting is happening just down the A1: Peterborough is quietly emerging as a compelling option for startups and scale-ups.
Babraham Research Campus launches Growth Office Hours to strengthen wraparound support for LiveLabs companies
Babraham Research Campus is delighted to announce the launch of its Growth Office Hours, a new initiative designed to enhance the wraparound support available to companies within LiveLabs.
CPFT leads national project to improve mental health treatments with biomarker data
A pioneering new data platform led by researchers at CPFT and the University of Cambridge is set to transform access to molecular data on mental health, which will help to develop targeted new treatments.
Position statement on integrating genomics into climate and health responses
PHG Foundation has released a position statement Precision health in a changing climate which we believe will be of interest to a wide range of professionals workin
Functional Genomics Screening Laboratory wins OBN Award for Most Impactful Industry Collaboration
The Functional Genomics Screening Laboratory, based at the Milner Therapeutics Institute, has won an OBN Award in the category of Most Impactful Industry Collaboration.
OBN Awards 2025 celebrate the most exciting innovations and inspiring achievements happening across the Life Sciences industry
Abingdon, UK, 27 November 2025: – OBN (UK) Ltd, the membership organisation whose mission is to catalyse success in the life science industry, is thrilled to announce the winners of the 17th annual OBN Awards, an evening organised by
Hospital bug jumps from lungs to gut, raising sepsis risk
A hospital-acquired bacterium that causes serious infections can move from the lungs to the gut inside the same patient, raising the risk of life-threatening sepsis, new research reveals.
Celtic Renewables appoints Allen Associates as it plans new biorefinery in Grangemouth
Tuesday 25 November 2025 – Celtic Renewables is moving forward with plans to build a new industrial-scale green chemical production plant in Grangemouth. It has appointed engineering design consultancy Allen Associates, part of the Forsyths Group of companies, to undertake extensive work to finalise the design of the proposed new facility.